2020 Form 10-K Financial Statement
#000156459021016107 Filed on March 29, 2021
Income Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
Revenue | $31.16M | $8.839M | $31.90M |
YoY Change | -2.3% | 37.47% | 28.25% |
Cost Of Revenue | $20.23M | $5.411M | $19.38M |
YoY Change | 4.4% | 33.01% | 27.41% |
Gross Profit | $10.93M | $3.428M | $12.52M |
YoY Change | -12.68% | 45.13% | 29.58% |
Gross Profit Margin | 35.07% | 38.78% | 39.24% |
Selling, General & Admin | $7.372M | $2.401M | $9.077M |
YoY Change | -18.78% | 16.78% | 10.31% |
% of Gross Profit | 67.45% | 70.04% | 72.52% |
Research & Development | $2.142M | $2.004M | |
YoY Change | 6.89% | 2.93% | |
% of Gross Profit | 19.6% | 16.01% | |
Depreciation & Amortization | $453.0K | $128.0K | $418.0K |
YoY Change | 8.37% | 5.79% | 0.24% |
% of Gross Profit | 4.14% | 3.73% | 3.34% |
Operating Expenses | $2.142M | $2.401M | $2.004M |
YoY Change | 6.89% | 16.78% | 2.93% |
Operating Profit | $1.415M | $1.027M | $3.439M |
YoY Change | -58.85% | 235.62% | 140.49% |
Interest Expense | -$273.0K | -$15.00K | -$14.00K |
YoY Change | 1850.0% | -1600.0% | -800.0% |
% of Operating Profit | -19.29% | -1.46% | -0.41% |
Other Income/Expense, Net | -$111.0K | $132.0K | $470.0K |
YoY Change | -123.62% | -607.69% | 235.71% |
Pretax Income | $1.304M | $1.144M | $3.909M |
YoY Change | -66.64% | 307.12% | 302.16% |
Income Tax | $336.0K | $179.0K | -$3.107M |
% Of Pretax Income | 25.77% | 15.65% | -79.48% |
Net Earnings | $968.0K | $965.0K | $7.016M |
YoY Change | -86.2% | 268.32% | 399.36% |
Net Earnings / Revenue | 3.11% | 10.92% | 22.0% |
Basic Earnings Per Share | $0.19 | $1.44 | |
Diluted Earnings Per Share | $0.19 | $96.26K | $1.41 |
COMMON SHARES | |||
Basic Shares Outstanding | 5.173M | 4.884M | |
Diluted Shares Outstanding | 5.217M | 4.978M |
Balance Sheet
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $24.12M | $18.08M | $18.08M |
YoY Change | 33.39% | -6.22% | -6.22% |
Cash & Equivalents | $18.33M | $12.45M | $12.45M |
Short-Term Investments | $5.791M | $5.631M | $5.631M |
Other Short-Term Assets | $257.0K | $365.0K | $365.0K |
YoY Change | -29.59% | 50.83% | 50.83% |
Inventory | $5.280M | $6.016M | $6.016M |
Prepaid Expenses | |||
Receivables | $4.122M | $4.445M | $4.445M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $33.78M | $28.91M | $28.91M |
YoY Change | 16.85% | 5.57% | 5.57% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $3.207M | $2.831M | $3.162M |
YoY Change | 1.42% | 35.71% | 51.58% |
Goodwill | $40.00K | ||
YoY Change | 0.0% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $3.072M | $3.334M | $3.334M |
YoY Change | -7.86% | ||
Other Assets | $3.068M | $102.0K | $3.409M |
YoY Change | -10.0% | -19.69% | 2584.25% |
Total Long-Term Assets | $9.674M | $10.31M | $10.31M |
YoY Change | -6.14% | 283.16% | 283.16% |
TOTAL ASSETS | |||
Total Short-Term Assets | $33.78M | $28.91M | $28.91M |
Total Long-Term Assets | $9.674M | $10.31M | $10.31M |
Total Assets | $43.46M | $39.22M | $39.22M |
YoY Change | 10.81% | 30.4% | 30.4% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.265M | $1.865M | $1.865M |
YoY Change | -32.17% | 31.52% | 31.52% |
Accrued Expenses | $2.132M | $2.219M | $2.219M |
YoY Change | -3.92% | 66.34% | 66.34% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.397M | $4.084M | $4.084M |
YoY Change | -16.82% | 48.4% | 48.4% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $293.0K | $240.0K | $240.0K |
YoY Change | 22.08% | ||
Total Long-Term Liabilities | $293.0K | $240.0K | $240.0K |
YoY Change | 22.08% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.397M | $4.084M | $4.084M |
Total Long-Term Liabilities | $293.0K | $240.0K | $240.0K |
Total Liabilities | $3.690M | $4.324M | $4.324M |
YoY Change | -14.66% | 57.12% | 57.12% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$6.153M | ||
YoY Change | -53.28% | ||
Common Stock | $41.63M | ||
YoY Change | 1.35% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $39.77M | $34.89M | $34.89M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $43.46M | $39.22M | $39.22M |
YoY Change | 10.81% | 30.4% | 30.4% |
Cashflow Statement
Concept | 2020 | 2019 Q4 | 2019 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $968.0K | $965.0K | $7.016M |
YoY Change | -86.2% | 268.32% | 399.36% |
Depreciation, Depletion And Amortization | $453.0K | $128.0K | $418.0K |
YoY Change | 8.37% | 5.79% | 0.24% |
Cash From Operating Activities | $3.192M | $1.577M | $2.666M |
YoY Change | 19.73% | 63.08% | 60.99% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $407.0K | -$337.0K | $1.163M |
YoY Change | -65.0% | 266.3% | 258.95% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$21.00K | $0.00 | -$5.000M |
YoY Change | -99.58% | -100.0% | |
Cash From Investing Activities | -$428.0K | -$337.0K | -$6.163M |
YoY Change | -93.06% | -102.77% | 1802.16% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 3.114M | 52.00K | 442.0K |
YoY Change | 604.52% | -285.71% | -52.27% |
NET CHANGE | |||
Cash From Operating Activities | 3.192M | 1.577M | 2.666M |
Cash From Investing Activities | -428.0K | -337.0K | -6.163M |
Cash From Financing Activities | 3.114M | 52.00K | 442.0K |
Net Change In Cash | 5.878M | 1.292M | -3.055M |
YoY Change | -292.41% | -90.15% | -235.3% |
FREE CASH FLOW | |||
Cash From Operating Activities | $3.192M | $1.577M | $2.666M |
Capital Expenditures | $407.0K | -$337.0K | $1.163M |
Free Cash Flow | $2.785M | $1.914M | $1.503M |
YoY Change | 85.3% | 80.74% | 12.84% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
33781000 | |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
28910000 | |
CY2020Q4 | us-gaap |
Land
Land
|
536000 | |
CY2019Q4 | us-gaap |
Land
Land
|
536000 | |
CY2020Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
4810000 | |
CY2019Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
4651000 | |
CY2020Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
17775000 | |
CY2019Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
17527000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
23121000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
5280000 | |
CY2019Q4 | us-gaap |
Inventory Net
InventoryNet
|
6016000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
257000 | |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
365000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18331000 | |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12453000 | |
CY2020Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
5791000 | |
CY2019Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
5631000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4122000 | |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4445000 | |
CY2019Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
402000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
422000 | |
CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
331000 | |
CY2020Q4 | lgl |
Equity Investment In Unconsolidated Subsidiary
EquityInvestmentInUnconsolidatedSubsidiary
|
3072000 | |
CY2019Q4 | lgl |
Equity Investment In Unconsolidated Subsidiary
EquityInvestmentInUnconsolidatedSubsidiary
|
3334000 | |
CY2020Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
327000 | |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
16000 | |
CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
102000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
43455000 | |
CY2019Q4 | us-gaap |
Assets
Assets
|
39217000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22714000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
20336000 | |
CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
19883000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2785000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2831000 | |
CY2020Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
3052000 | |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1865000 | |
CY2019Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
3307000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1324000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1265000 | |
CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1832000 | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
808000 | |
CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
387000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3397000 | |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4084000 | |
CY2020Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
293000 | |
CY2019Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
240000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
3690000 | |
CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
4324000 | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
53000 | |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
50000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
45477000 | |
CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
41576000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5185000 | |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6153000 | |
CY2020Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
580000 | |
CY2019Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
580000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
39765000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34893000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
43455000 | |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
39217000 | |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
189000 | |
CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
109000 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5409550 | |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5014647 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5272204 | |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4933063 | |
CY2020Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
81584 | |
CY2019Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
81584 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
31162000 | |
CY2019 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
31897000 | |
CY2019 | lgl |
Engineering Selling And Administrative
EngineeringSellingAndAdministrative
|
9077000 | |
CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
3439000 | |
CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-111000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
968000 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5173430 | |
CY2019 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4883923 | |
CY2020 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.19 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27323000 | |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5216859 | |
CY2019 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.44 | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
15508000 | |
CY2019 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4977595 | |
CY2020 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.19 | |
CY2019 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.41 | |
CY2019 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
442000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
85000 | |
CY2020 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
23000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
790000 | |
CY2020 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3254000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
202000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
968000 | |
CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
7016000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
453000 | |
CY2019 | us-gaap |
Depreciation
Depreciation
|
418000 | |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
75000 | |
CY2019 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
75000 | |
CY2020 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-262000 | |
CY2019 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-16000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
790000 | |
CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
112000 | |
CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
255000 | |
CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-3180000 | |
CY2020 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
139000 | |
CY2019 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
206000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-323000 | |
CY2019 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1051000 | |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-736000 | |
CY2019 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1550000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-194000 | |
CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
225000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-725000 | |
CY2019 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1241000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3192000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2666000 | |
CY2020 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
21000 | |
CY2019 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
5050000 | |
CY2019 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
3350000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
407000 | |
CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1163000 | |
CY2019 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
3400000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-428000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-6163000 | |
CY2020 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
3254000 | |
CY2020 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
202000 | |
CY2020 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
62000 | |
CY2019 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
442000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3114000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
442000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5878000 | |
CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3055000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12453000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18331000 | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3000 | |
CY2019 | us-gaap |
Interest Paid Net
InterestPaidNet
|
6000 | |
CY2020 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
60000 | |
CY2019 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
86000 | |
CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Uses of Estimates</p> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. | |
CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration Risks</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, the Company's largest customer, a defense contract manufacturer, accounted for $5,324,000, or 17.1%, of the Company's total revenues, compared to $3,187,000, or 10.0%, of the Company’s total revenues in 2019. The Company’s second largest customer, an electronics contract manufacturing company, accounted for $4,351,000, or 14.0%, of the Company's total revenues, compared to $5,522,000, or 17.3%,<font style="font-family:Calibri;"> </font>of the Company’s total revenues<font style="font-family:Calibri;"> </font>in 2019.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of December 31, 2020, four of the Company's largest customers accounted for approximately $1,856,000, or 43.1%, of accounts receivable. As of December 31, 2019, four of the Company's largest customers accounted for approximately $1,841,000, or 40%, of accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit and utilizes letters of credit to further limit credit risk for export sales. As a result of these policies, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p> At various times throughout the year and at December 31, 2020 and 2019, some deposits held at financial institutions were in excess of federally insured limits. The Company has not experienced any losses related to these balances. | |
CY2020 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | |
CY2019 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
63000 | |
CY2020Q4 | lgl |
Finite Lived Intangible Asset Expected Amortization Year Five And Thereafter
FiniteLivedIntangibleAssetExpectedAmortizationYearFiveAndThereafter
|
36000 | |
CY2020 | lgl |
Term Of Warranty
TermOfWarranty
|
P1Y | |
CY2020Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
21000 | |
CY2019Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
29000 | |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2142000 | |
CY2019 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2004000 | |
CY2020 | lgl |
Warrants To Purchase Common Shares
WarrantsToPurchaseCommonShares
|
1051664 | |
CY2019 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-3344000000 | |
CY2020 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | |
CY2020 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-95000 | |
CY2019 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-13000 | |
CY2020Q4 | us-gaap |
Assets Under Management Carrying Amount
AssetsUnderManagementCarryingAmount
|
19063000 | |
CY2019Q4 | us-gaap |
Assets Under Management Carrying Amount
AssetsUnderManagementCarryingAmount
|
14536000 | |
CY2020Q4 | lgl |
Number Of Mutual Fund Investment
NumberOfMutualFundInvestment
|
2 | |
CY2019Q4 | lgl |
Number Of Mutual Fund Investment
NumberOfMutualFundInvestment
|
2 | |
CY2020Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
1219000 | |
CY2019Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
1015000 | |
CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2080000 | |
CY2019Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2134000 | |
CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2467000 | |
CY2019Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2640000 | |
CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
733000 | |
CY2019Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
1242000 | |
CY2019Q3 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-3344000000 | |
CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
31000 | |
CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
30000 | |
CY2020 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
50000 | |
CY2019 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
43000 | |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
81000 | |
CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
73000 | |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
238000 | |
CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
1322000 | |
CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-6000 | |
CY2019 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
147000 | |
CY2020 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
32000 | |
CY2019 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
60000 | |
CY2020 | lgl |
Deferred Income Tax Expense Benefit Before Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitBeforeChangeInValuationAllowance
|
264000 | |
CY2019 | lgl |
Deferred Income Tax Expense Benefit Before Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitBeforeChangeInValuationAllowance
|
1529000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-9000 | |
CY2019 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-4709000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
274000 | |
CY2019 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
821000 | |
CY2020 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
31000 | |
CY2019 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
92000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
45000 | |
CY2019 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
34000 | |
CY2020 | lgl |
Income Tax Reconciliation Tax Credits Adjustments
IncomeTaxReconciliationTaxCreditsAdjustments
|
7000 | |
CY2019 | lgl |
Income Tax Reconciliation Tax Credits Adjustments
IncomeTaxReconciliationTaxCreditsAdjustments
|
-108000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
1000 | |
CY2019 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
13000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
-38000 | |
CY2020 | lgl |
Income Tax Reconciliation Provision To Return
IncomeTaxReconciliationProvisionToReturn
|
15000 | |
CY2019 | lgl |
Income Tax Reconciliation Provision To Return
IncomeTaxReconciliationProvisionToReturn
|
0 | |
CY2020 | lgl |
Income Tax Reconciliation Permanent True Ups
IncomeTaxReconciliationPermanentTrueUps
|
0 | |
CY2019 | lgl |
Income Tax Reconciliation Permanent True Ups
IncomeTaxReconciliationPermanentTrueUps
|
687000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
10000 | |
CY2019 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
0 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
286000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
239000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
|
us-gaap:OtherLiabilitiesMember | |
CY2020Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
12.50 | |
CY2020Q4 | lgl |
Common Stock Distribution Value
CommonStockDistributionValue
|
5258320000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
311000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
358000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
8000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
6000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
|
1717000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
|
1724000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
892000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
1169000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
252000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
250000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
35000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
67000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3501000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3813000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
379000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
388000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
3052000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
3307000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
58000 | |
CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
100000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
12000 | |
CY2019Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
18000 | |
CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
70000 | |
CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
118000 | |
CY2020Q4 | lgl |
Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
|
3500000 | |
CY2020 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2020 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
188000000 | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
611000000 | |
CY2019 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
564000000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
422000000 | |
CY2019Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
129000000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
137000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
112000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
112000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
112000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
13000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
486000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
64000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
422000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
|
The expected life of 5 years was based on the estimated term of the Common Stock Warrants, the volatility factor of 46.5% was based on historical volatilities of the Company’s common stock and the exercise price of $12.50 per share of the Company’s common stock was based on the terms of the warrant agreement. | |
CY2020 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
13000000 | |
CY2020 | lgl |
Common Stock Issuance Cost
CommonStockIssuanceCost
|
202000 | |
CY2011Q3 | us-gaap |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
100000 | |
CY2020Q4 | us-gaap |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
540000 | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
78379 | |
CY2020 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
20329 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
58050 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
38123 | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.43 | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
4.21 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.56 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
6.80 | |
CY2019Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
2.00 | |
CY2020 | lgl |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
|
0.98 | |
CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
2.37 | |
CY2020Q4 | lgl |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
|
1.66 | |
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y8M12D | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y6M | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P1Y10M24D | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
593000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
236000 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.50 | |
CY2020 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
0.06 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
119000 | |
CY2019 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
115000 | |
CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
220000 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.40 | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y6M18D | |
CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0163 | |
CY2020 | us-gaap |
Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
|
0.20 | |
CY2020 | lgl |
Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
|
P6Y | |
CY2020 | lgl |
Vesting Percentage Of Employer Contributions By Year Six
VestingPercentageOfEmployerContributionsByYearSix
|
1.00 | |
CY2020 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
407000 | |
CY2019 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
1163000 |